200 related articles for article (PubMed ID: 10824708)
1. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS).
Schranz DB; Bekris L; Landin-Olsson M; Törn C; Niläng A; Toll A; Sjöström J; Grönlund H; Lernmark A
Horm Metab Res; 2000 Apr; 32(4):133-8. PubMed ID: 10824708
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.
Falorni A; Calcinaro F
Ann N Y Acad Sci; 2002 Apr; 958():99-106. PubMed ID: 12021088
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus.
Ng WY; Lee YS; Todd AL; Lui KF; Loke KY; Thai AC
Autoimmunity; 2002 Mar; 35(2):119-24. PubMed ID: 12073931
[TBL] [Abstract][Full Text] [Related]
4. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
Gambelunghe G; Forini F; Laureti S; Murdolo G; Toraldo G; Santeusanio F; Brunetti P; Sanjeevi CB; Falorni A
Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
[TBL] [Abstract][Full Text] [Related]
5. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
[TBL] [Abstract][Full Text] [Related]
6. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
[TBL] [Abstract][Full Text] [Related]
7. GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patients.
Maruyama T; Oak S; Shimada A; Hampe CS
Diabetes Care; 2008 Aug; 31(8):1602-7. PubMed ID: 18487477
[TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetes-related autoantibodies are rare in Alaska native populations.
Mohatt J; Gilliam LK; Bekris L; Ebbesson S; Lernmark A
Int J Circumpolar Health; 2002 Feb; 61(1):21-31. PubMed ID: 12002943
[TBL] [Abstract][Full Text] [Related]
9. GAD65 and IA-2 autoantibodies are common in a subset of siblings of Sardinian Type 2 diabetes families.
Maioli M; Tonolo G; Bekris L; Cirillo R; Schranz D; Cossu E; Ciccarese M; Lernmark A;
Diabetes Res Clin Pract; 2002 Apr; 56(1):41-7. PubMed ID: 11879720
[TBL] [Abstract][Full Text] [Related]
10. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
Hampe CS; Hall TR; Agren A; Rolandsson O
Clin Exp Immunol; 2007 Apr; 148(1):72-8. PubMed ID: 17286757
[TBL] [Abstract][Full Text] [Related]
12. A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS).
Schranz DB; Bekris L; Landin-Olsson M; Törn C; Niläng A; Toll A; Grönlund H; Toivola B; Lernmark A
J Immunol Methods; 1998 Apr; 213(1):87-97. PubMed ID: 9671127
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: prevalence and correlation with clinical features.
Grasso YZ; Reddy SK; Rosenfeld CR; Hussein WI; Hoogwerf BJ; Faiman C; Gupta MK
Endocr Pract; 2001; 7(5):339-45. PubMed ID: 11585368
[TBL] [Abstract][Full Text] [Related]
14. Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.
Premawardhana LD; Wijeyaratne CN; Chen S; Wijesuriya M; Illangasekera U; Brooking H; Amoroso M; Jeffreys J; Bolton J; Lazarus JH; Furmaniak J; Rees Smith B
J Endocrinol Invest; 2006 Dec; 29(11):968-74. PubMed ID: 17259793
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody against IA-2 improves the test sensitivity for insulin-dependent diabetes mellitus in Japanese patients of child onset.
Kasuga A; Ozawa Y; Maruyama T; Ishihara T; Amemiya S; Saruta T
Endocr J; 1997 Aug; 44(4):485-91. PubMed ID: 9447280
[TBL] [Abstract][Full Text] [Related]
16. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
Li X; Yang L; Zhou Z; Huang G; Yan X
Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.
Hagopian WA; Karlsen AE; Gottsäter A; Landin-Olsson M; Grubin CE; Sundkvist G; Petersen JS; Boel E; Dyrberg T; Lernmark A
J Clin Invest; 1993 Jan; 91(1):368-74. PubMed ID: 8423232
[TBL] [Abstract][Full Text] [Related]
18. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
[TBL] [Abstract][Full Text] [Related]
19. IA-2 autoantibodies are predominant in latent autoimmune diabetes in adults patients from eastern India.
Kanungo A; Sanjeevi CB
Ann N Y Acad Sci; 2003 Nov; 1005():390-4. PubMed ID: 14679098
[TBL] [Abstract][Full Text] [Related]
20. Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.
Nakamura K; Kawasaki E; Abiru N; Jo O; Fukushima K; Satoh T; Kuriya G; Kobayashi M; Kuwahara H; Yamasaki H; Ide T; Eguchi K
Endocr J; 2010; 57(11):947-51. PubMed ID: 20805634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
